Every Form 4 that Procter & Gamble Company (PG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PG filings page.
Procter & Gamble Co. director Rajesh Subramaniam received 1,438 restricted stock units on October 13, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. His reported direct position afterward was 7,768 shares; that total includes dividend equivalents granted as restricted stock units.
Procter & Gamble (PG) director Robert Jones Portman acquired 1,438 restricted stock units on October 13, 2026. The award was reported as a direct transaction, with 6,685 shares of common stock held following the transaction.
Procter & Gamble director Ashley McEvoy acquired 1,438 shares of common stock on October 13, 2026, as an award under the Procter & Gamble 2025 Stock and Incentive Compensation Plan. Her reported direct holdings after the award were 7,666 shares.
Procter & Gamble director Christine M. McCarthy received an award of 1,438 restricted stock units on October 13, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Her reported direct holdings following the award were 19,342 shares. The transaction was a compensation-related award, not a reported market purchase or sale.
Procter & Gamble director Christopher J. Kempczinski received an award of 1,438 restricted stock units on October 13, 2026. The report lists 13,372 shares of common stock directly held after the award. This was a compensation-related acquisition, not a market purchase.
Procter & Gamble (PG) director Joseph Jimenez acquired 1,438 shares of common stock on October 13, 2026, through an award of restricted stock units. His reported direct common-stock position following the award was 38,968 shares. The award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Procter & Gamble director Amy Chang acquired 1,438 restricted stock units on October 13, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Her reported direct holdings after the transaction were 18,897 shares. The award total includes dividend equivalents in the form of restricted stock units.
Procter & Gamble director Sheila Bonini acquired 1,438 restricted stock units on October 13, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Her reported direct position afterward was 5,983 shares; the total includes a grant of dividend equivalents in the form of restricted stock units.
Procter & Gamble director M. Brett Biggs received an award of 1,438 Restricted Stock Units on October 13, 2026, under the company’s 2025 Stock and Incentive Compensation Plan. His reported post-transaction position was 6,900 shares; the reported total includes dividend equivalents granted as Restricted Stock Units.
Procter & Gamble director Craig Arnold acquired 1,438 restricted stock units on October 13, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. This was a compensation-related award, not a market purchase. After the award, he directly held 4,474 shares of common stock.
Procter & Gamble director Bertrand Marc Allen received an award of 1,438 restricted stock units on October 13, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. His reported direct position afterward was 12,698 shares; the total includes dividend equivalents granted as restricted stock units.
Procter & Gamble Chief Financial Officer Andre Schulten sold 3,914 common shares on October 5, 2026, at $145.34 per share. A footnote says the shares were sold to cover tax obligations upon settlement of a Restricted Stock Unit Award. After the transaction, he directly held 65,618 shares. The reported indirect position through the Retirement Plan Trustee was 7,604 shares, reflecting an adjustment to PST through September 30, 2026.
Procter & Gamble CEO- Health Care Paul Gama sold 2,225 common shares at $145.34 per share on October 5, 2026, to cover a tax obligation upon settlement of a Restricted Stock Unit award. After the sale, he directly held 51,124 common shares. A separate indirect holding through the Retirement Plan Trustee was 1,184 shares; that amount reflects an adjustment to PST through September 30, 2026. No Rule 10b5-1 plan is reported.
Procter & Gamble Chief Legal Officer and Secretary Susan Street Whaley reported selling 2,369 common shares on October 5, 2026, at $145.34 per share. The shares were sold to cover tax obligations upon settlement of a restricted stock unit award. Whaley held 30,730 shares directly after the sale. A separate entry lists 7,254 shares indirectly through the Retirement Plan Trustee; the entry reflects an adjustment to PST through September 30, 2026.
Procter & Gamble reported that Chief Legal Officer & Secy Susan Street Whaley received 24,330 stock options to buy common shares, with a $143.95 exercise price; they are scheduled to become exercisable October 1, 2029, and expire October 1, 2036. She was also awarded 6,110 Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, bringing her reported direct common-stock holdings to 33,099 shares. A separate entry lists 7,188 shares held indirectly by a Retirement Plan Trustee.
Procter & Gamble reported that Chief Financial Officer Andre Schulten was awarded 78,324 stock options and 6,557 restricted stock units on October 1, 2026. The options have a $143.95 exercise price, are exercisable on October 1, 2029, and expire October 1, 2036; the restricted stock units were awarded under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following the awards, Schulten’s direct common stock holdings were 69,532 shares; 7,535 shares were held indirectly by the Retirement Plan Trustee.
Procter & Gamble’s CEO- Health Care, Paul Gama, received an award of 12,517 restricted stock units on October 1, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. After the award, his reported direct common-stock holdings were 53,349 shares. A separate position lists 1,173 common shares held indirectly by the Retirement Plan Trustee.
Procter & Gamble CEO Shailesh Jejurikar received 16,065 restricted stock units on October 1, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and a stock-option award covering 191,909 common shares. His reported direct common stock holdings after the RSU award were 55,391 shares. As of October 1, 2026, his reported indirect common stock holdings included 3,742 shares through a retirement plan trustee, 19,757 shares in Sankhya S Jejurikar Revocable Trust and 35,836 shares in Shailesh Jejurikar Trust.
Procter & Gamble (PG) Chf Rsch, Dev & Innov Officer Moses Victor Javier Aguilar reported awards dated October 1, 2026: stock options covering 22,822 common shares and 5,732 restricted stock units. The options have a $143.95 per-share exercise price. After the restricted stock unit award, direct common-stock holdings were 55,243 shares. As of October 1, 2026, indirect holdings included 7,476 shares through the Retirement Plan Trustee and 429 shares through the International Stock Ownership Plan (Mexico) Trustee.
Procter & Gamble reported awards to CEO - Grooming de Azevedo Juliana Monteiro Santos on October 1, 2026: options to buy 37,382 shares of common stock at a $143.95 exercise price and 3,130 restricted stock units under its 2025 Stock and Incentive Compensation Plan. Following the RSU award, reported direct common-stock holdings were 26,731 shares; indirect holdings listed were 164 shares by the Retirement Plan Trustee and 331 shares in the International Stock Ownership Plan & Pension Plan.
Procter & Gamble officer Freddy P. Bharucha, CEO - Beauty, received stock option awards on October 1, 2026: 49,843 options held directly and 3,126 held indirectly by his spouse. The reported option positions after the awards were 49,843 and 3,126, respectively. Both awards have an exercise price of $143.95 per share, an exercise date of October 1, 2029, and an expiration date of October 1, 2036.
Procter & Gamble SVP - Chief Accounting Officer Matthew W. Janzaruk received an award of 13,648 stock options on October 1, 2026. His reported direct option position after the award was 13,648. The options have an exercise price of $143.95, an exercise date of October 1, 2029, and an expiration date of October 1, 2036. His reported common stock holdings were 1,271 shares held directly and 3,889 shares held indirectly through a retirement plan trustee.
Procter & Gamble Chief Brand Officer Marc S. Pritchard received a grant of 44,994 stock options on October 1, 2026. The options have an exercise price of $143.95 per share, an exercise date of October 1, 2029, and an expiration date of October 1, 2036. His reported option position after the grant was 44,994 options.
Procter & Gamble CEO-Fabric Home & Habitat Care Sundar G. Raman received a direct award of 69,780 stock options on October 1, 2026. The options have an exercise price of $143.95 per share, an exercise date of October 1, 2029, and an expiration date of October 1, 2036. The filing also lists 47,745 common shares held directly and 9,146 held indirectly through a Retirement Plan Trustee.
Procter & Gamble Chief Human Resources Officer Balaji Purushothaman received an award of 39,160 stock options on October 1, 2026. The options have an exercise price of $143.95 per share. As of October 1, 2026, he reported direct ownership of 15,477 common shares and indirect ownership of 5,820 common shares held by a retirement plan trustee.
Procter & Gamble (PG) reported a grant of 41,536 stock options to El Hak Hesham Abd, CEO-Baby and Feminine Care, on October 1, 2026. The options have a $143.95 exercise price, an exercise date of October 1, 2029, and an expiration date of October 1, 2036. Reported common-stock holdings after the transaction were 11,218 shares directly, 1,529 shares indirectly by Retirement Plan Trustee, and 44 shares indirectly through International Stock Ownership Plan & Pension Plan.
PROCTER & GAMBLE Co (PG) reports that Freddy P. Bharucha, CEO – Beauty, received a grant of 9,271 stock options on September 15, 2026. The options allow him to buy an equal number of common shares at an exercise price of $146.67, exercisable from September 14, 2029 and expiring September 15, 2036. Following this grant, he holds these options directly and also has direct and indirect common stock holdings, including 1,965.4595 shares held directly and additional shares held through retirement and spousal accounts. No Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that Chief Human Resources Officer Purushothaman Balaji received a grant of 12,336 stock options on September 15, 2026. The options carry an exercise price of $146.67 per share and are scheduled to become exercisable on September 14, 2029, expiring on September 15, 2036. After this grant, Balaji holds these 12,336 options directly, along with 15,476.7953 shares of common stock directly and 5,820.1949 shares indirectly through a retirement plan trustee. No Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that Chairman, President and CEO Shailesh Jejurikar received a grant of stock options on September 15, 2026. The award covers 22,787 options to acquire an equal number of shares of common stock at an exercise price of $146.67 per share, expiring on September 15, 2036.
After this grant, he holds 22,787 stock options directly. His reported common stock positions total 39,325.9973 shares held directly and additional indirect holdings through a retirement plan and two trusts.
PROCTER & GAMBLE Co (PG) reported that Juliana Monteiro Santos de Azevedo, CEO - Grooming, received a grant of stock options on September 15, 2026 to acquire 14,476 shares of common stock at an exercise price of $146.67 per share, expiring September 15, 2036 and exercisable beginning September 14, 2029. Following this grant, she holds 23,601.2363 shares of common stock directly, plus indirect holdings of 163.6046 shares through a Retirement Plan Trustee and 331.21 shares through an International Stock Ownership Plan & Pension Plan. No Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that Moses Victor Javier Aguilar, the company’s Chief Research, Development & Innovation Officer, received a grant of stock options for 3,519 shares on September 15, 2026, with an exercise price of $146.67 per share, exercisable beginning September 14, 2029 and expiring September 15, 2036. Following this grant, he holds 49,511.0935 shares of common stock directly, plus 7,476.1294 shares held through a retirement plan trustee and 428.6033 shares held through an International Stock Ownership Plan (Mexico) trustee; no Rule 10b5-1 trading plan is reported.
PROCTER & GAMBLE Co (PG) reported that director Robert Jones Portman received an award of 52 Restricted Stock Units (RSUs) of common stock on September 8, 2026, as a grant or other acquisition under compensation arrangements. Following this award, he directly holds 5,246.6454 shares (including RSUs and related dividend equivalents). No Rule 10b5-1 trading plan is reported for this transaction.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC. McEvoy Ashley reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co (PG) reported that director Ashley McEvoy received an equity award of 207 shares of Common Stock on September 8, 2026, at a stated price of $0.00 per share. The award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in the form of Restricted Stock Units. Following this grant, McEvoy directly holds 6,228.0049 shares of PG common stock.
PROCTER & GAMBLE Co (PG) reported that director Christine M. McCarthy received an award of 258 Restricted Stock Units of common stock on September 8, 2026, as a grant or award acquisition under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following this award (including dividend-equivalent RSUs), she directly holds 17,903.7543 shares-equivalent of PG common stock. No Rule 10b5-1 trading plan is reported for this Form 4.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC. Kempczinski Christopher J reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co (PG) reported that director Christopher J. Kempczinski received an award of 250 Restricted Stock Units (RSUs) of common stock on September 8, 2026. The RSUs were granted at $0.00 per share under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and include dividend equivalents in the form of additional RSUs. Following this grant, Kempczinski directly holds 11,933.6723 shares of Procter & Gamble common stock.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC. JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co (PG) reported that director Joseph Jimenez received an award of 327 Restricted Stock Units of common stock on September 8, 2026, at no cash cost to him, pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following this award, his directly held balance increased to 37,529.634 shares-equivalent, which the company states includes previously granted dividend equivalents in the form of Restricted Stock Units.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC. ARNOLD CRAIG reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co (PG) director Craig Arnold reported an equity compensation award in the form of 207 Restricted Stock Units on September 8, 2026, granted at no cash cost to him under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. After this award and related dividend equivalents, he directly holds 3,036.1836 shares/units-equivalent of common stock. No Rule 10b5-1 trading plan is reported for this filing.
PROCTER & GAMBLE Co (PG) reported an amended insider transaction for officer Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer. The amendment states it only corrects the date of a previously reported stock sale.
On August 20, 2026, Aguilar sold 3,053 shares of common stock at $143.79 per share, with shares sold to cover taxes on a stock award. After this sale, he held 49,511.0935 shares directly, plus indirect holdings of 7,476.1294 shares through a retirement plan trustee and 428.6033 shares through the International Stock Ownership Plan (Mexico) trustee.
PROCTER & GAMBLE Co (PG) reported an insider transaction by Matthew W. Janzaruk, SVP - Chief Accounting Officer. On 2026-08-24, he sold 359 shares of Common Stock at $145.24 per share in an open market or private transaction. After this sale, he held 1,271.2791 shares directly and 3,888.7974 shares indirectly through a Retirement Plan Trustee. The Rule 10b5-1 trading plan checkbox was not marked as applicable.
PROCTER & GAMBLE Co (PG) reported an insider transaction by Moses Victor Javier Aguilar, its Chief Research, Development & Innovation Officer. On 2026-08-19, he sold 3,053 shares of common stock at $143.79 per share, with a footnote stating the shares were sold to cover taxes on a Stock Award. After this sale, he held 49,511.0935 shares directly, plus indirect holdings of 7,476.1294 shares through a retirement plan trustee and 428.6033 shares through an International Stock Ownership Plan (Mexico) trustee.
PROCTER & GAMBLE Co (PG) insider Hesham Abd El Hak, CEO of Baby and Feminine Care, reported selling 1,936 shares of common stock on 2026-08-20 at $143.79 per share. A footnote states the shares were sold to cover taxes on a stock award. After the sale, he held 11,217.9294 shares directly, plus indirect holdings through a retirement plan and an international stock ownership and pension plan.
PROCTER & GAMBLE Co (PG) reported that executive Sundar G. Raman, CEO-Fabric Home & Habitat Care, sold 3,435 shares of common stock on 2026-08-21 at $143.02 per share. A footnote states the shares were sold to cover taxes on a Stock Award. After this, he holds 47,744.8463 shares directly and 9,145.8364 shares indirectly through a retirement plan trustee.
PROCTER & GAMBLE Co (PG) reported an insider transaction by Juliana Monteiro Santos de Azevedo, CEO – Grooming. She sold 2,368 shares of common stock on August 20, 2026 at $143.79 per share, with a footnote stating the shares were sold to cover taxes on a stock award. After the sale, she held 23,601.2363 shares directly, plus indirect holdings of 163.6046 shares through a retirement plan trustee and 331.2100 shares through an international stock ownership and pension plan.
PROCTER & GAMBLE Co (PG) reported an insider transaction by Matthew W. Janzaruk, SVP - Chief Accounting Officer. On 2026-08-20, he sold 156 shares of Common Stock at $143.79 per share, with a footnote stating the shares were sold to cover taxes on a Stock Award. After this sale, he directly held 1,630.2791 shares. He also had an indirect holding of 3,888.7974 shares of Common Stock held by a Retirement Plan Trustee.
PROCTER & GAMBLE Co (PG) reported that Chief Financial Officer Andre Schulten sold 5,402 shares of common stock on 2026-08-20 at a price of $143.79 per share. According to the footnote, the shares were sold to cover taxes on a Stock Award. After this sale, he directly held 62,975.0097 shares and indirectly held 7,535.1091 shares through a retirement plan trustee.
PROCTER & GAMBLE Co (PG) reported that Freddy P. Bharucha, its CEO - Beauty, sold 246 shares of common stock on August 20, 2026 at $143.79 per share. The filing explains that these shares were sold to cover taxes on a Stock Award. After the sale, he directly held 1,965.4595 shares and also reported several indirect holdings through a retirement plan trustee and his spouse.
PROCTER & GAMBLE Co (PG) reported that Chief Human Resources Officer Purushothaman Balaji sold 2,019 shares of common stock on 2026-08-20 at $143.79 per share. The company disclosure states these shares were sold to cover taxes on a Stock Award. Following the sale, Balaji holds 15,476.7953 shares directly and 5,820.1949 shares indirectly through a retirement plan trustee.
PROCTER & GAMBLE Co (PG) reported that Chairman, President and CEO Shailesh Jejurikar sold 6,176 shares of common stock on 2026-08-20 at $143.79 per share. The company notes the shares were sold to cover taxes on a Stock Award. Following this sale, he directly holds 39,325.9973 shares, with additional indirect holdings through a retirement plan and personal trusts.
PROCTER & GAMBLE Co (PG) officer Paul Gama, CEO–Health Care, reported selling 3,396 shares of common stock on August 20, 2026 at $143.79 per share. A footnote states the shares were sold to cover taxes on a Stock Award. Following this sale, he holds 40,831.8803 shares directly and 1,173.4717 shares indirectly through a Retirement Plan Trustee.
PROCTER & GAMBLE Co (PG) reported that Chief Legal Officer & Secretary Susan Street Whaley sold 2,238 shares of Common Stock on 2026-08-20 at $143.79 per share. A footnote states the shares were sold to cover taxes on a Stock Award. After this sale, she holds 26,988.9685 shares directly and 7,187.9174 shares indirectly through a Retirement Plan Trustee.